Gilman Kuric Tihana, Popovic Zvonimir, Matosa Sara, Sadikov Aleksander, Groznik Vida, Georgiev Dejan, Gerbasi Alessia, Kragujevic Jagoda, Mirosevic Zubonja Tea, Krivdic Dupan Zdravka, Guljas Silva, Kuric Igor, Juric Stjepan, Palic Kramaric Ruzica, Tomic Svetlana
Department of Neurology, Osijek University Hospital Center, 31000 Osijek, Croatia.
Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
J Clin Med. 2024 Sep 25;13(19):5708. doi: 10.3390/jcm13195708.
Cervical dystonia (CD) is a condition characterized by involuntary activity of cervical muscles, which is often accompanied by various non-motor symptoms. Recent studies indicate impaired saccadic eye movements in CD. Local administration of botulinum toxin type A (BoNT/A), which causes temporary paralysis of the injected muscle, is the first-line treatment of focal dystonia, including CD. To our knowledge, concurrent observation of the effect of BoNT/A on smooth eye movements, voluntary saccades, memory-guided saccades, and antisaccades in CD has not yet been explored. The aim of this study was to assess the effect of BoNT/A on eye movements and non-motor symptoms in patients with CD, which, when altered, could imply a central effect of BoNT/A. Thirty patients with CD performed smooth pursuit, prosaccadic expression, memory-guided saccades, and antisaccade tasks; eye movements were recorded by an eye tracker. Motor and non-motor symptoms, including depression, anxiety, pain, disability, and cognitive changes prior to and after BoNT/A administration, were also evaluated. The number of correct onward counts ( < 0.001), overall correct memory-guided saccades count ( = 0.005), motor symptoms ( = 0.001), and non-motor symptoms, i.e., anxiety ( = 0.04), depression ( = 0.02), and cognition ( < 0.001) markedly improved after BoNT/A administration. Memory-guided saccades, depression, and anxiety improve after BoNT/A in CD.
颈部肌张力障碍(CD)是一种以颈部肌肉不自主活动为特征的疾病,常伴有各种非运动症状。最近的研究表明CD患者的扫视眼动存在受损。局部注射A型肉毒毒素(BoNT/A)可导致注射肌肉暂时麻痹,是包括CD在内的局灶性肌张力障碍的一线治疗方法。据我们所知,尚未探讨BoNT/A对CD患者平稳眼动、随意扫视、记忆引导扫视和反扫视的影响。本研究的目的是评估BoNT/A对CD患者眼动和非运动症状的影响,当这些发生改变时,可能意味着BoNT/A具有中枢效应。30例CD患者进行了平稳跟踪、同向扫视、记忆引导扫视和反扫视任务;通过眼动追踪仪记录眼动。还评估了BoNT/A注射前后的运动和非运动症状,包括抑郁、焦虑、疼痛、残疾和认知变化。BoNT/A注射后,正确向前计数的数量(<0.001)、记忆引导扫视的总体正确计数(=0.005)、运动症状(=0.001)以及非运动症状,即焦虑(=0.04)、抑郁(=0.02)和认知(<0.001)均有明显改善。CD患者在接受BoNT/A治疗后,记忆引导扫视、抑郁和焦虑症状有所改善。